Phosphate for Pancreatitis

(PPP Trial)

This trial explores whether administering phosphate through an IV can help treat acute pancreatitis, a condition that causes sudden inflammation in the pancreas, by making it less severe. Researchers aim to determine if low phosphate levels increase the risk of this illness and if phosphate can improve its management. Participants will receive either standard care or an IV phosphate treatment (using Potassium Phosphate or Sodium Phosphate) and will undergo regular blood tests. This study targets adults who arrive at the Duke University Hospital emergency department with severe abdominal pain and meet specific lab criteria for pancreatitis. As a Phase 2 trial, this research focuses on assessing the treatment's effectiveness in an initial, smaller group, offering participants a chance to contribute to significant medical advancements.

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

Research has shown that phosphate plays a crucial role in healing from acute pancreatitis, a sudden swelling of the pancreas. It aids in cell repair after damage. Some studies suggest that low phosphate levels can worsen pancreatitis. Experiments have demonstrated that adding phosphate can reduce the severity of the condition.

For safety, the researchers are examining two types of phosphate: potassium phosphate and sodium phosphate. Careful administration of these treatments is essential. Reports indicate that incorrect administration of potassium phosphate can cause serious issues. However, when used properly, phosphate is generally safe.

Researchers are excited about using phosphate treatments for pancreatitis because they offer a novel approach by directly targeting phosphorus levels in the body. Unlike standard treatments that primarily focus on managing symptoms and providing supportive care, these phosphate infusions aim to correct hypophosphatemia, which can be common in pancreatitis patients. The continuous administration of sodium or potassium phosphate, adjusted based on the patient's serum phosphorus levels, could potentially stabilize the patient's condition more rapidly and effectively during their hospital stay. This targeted approach and its potential for quicker intervention make it a promising option in managing acute pancreatitis.

Research has shown that phosphate levels can affect acute pancreatitis, a sudden swelling of the pancreas. Some studies have found that low phosphate levels, known as hypophosphatemia, might worsen the condition. In animal studies, adding phosphate reduced the severity of pancreatitis. Maintaining normal phosphate levels aids cell repair after injury, potentially supporting recovery. In this trial, participants in the Phosphate Treatment Phase will receive sodium phosphate or potassium phosphate to assess potential benefits. Although limited information exists on phosphate treatment's effectiveness for humans with acute pancreatitis, these findings suggest it might help manage the condition.³⁶⁷⁸⁹